Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience
Advances in Chronic Kidney Disease · 2019-07 · 26 (4) · 253-266
DOI: 10.1053/j.ackd.2019.04.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Chronic Kidney Disease, 2019-07. Verfasst von Neil S Sanghani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Die Arbeit wurde bisher 175-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Vanderbilt University, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; Department of Medical Cell Biology, Uppsala Universitet, Uppsala, Sweden; Department of Molecular Physiology & Biophysics and Program in Cance…
Förderung
- NIDDK NIH HHS
- Vanderbilt University
- National Institutes of Health
Zitieren
APA
Sanghani, N. S., & Haase, V. H. (2019). Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience. Advances in Chronic Kidney Disease, 26(4), 253-266. https://doi.org/10.1053/j.ackd.2019.04.004
Vancouver
Sanghani NS, Haase VH. Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience. Advances in Chronic Kidney Disease. 2019;26(4):253-266. doi:10.1053/j.ackd.2019.04.004
BibTeX
@article{Sanghani2019,
author = {Sanghani, Neil S and Haase, Volker H},
title = {Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience},
journal = {Advances in Chronic Kidney Disease},
year = {2019},
volume = {26},
number = {4},
pages = {253--266},
doi = {10.1053/j.ackd.2019.04.004}
}
EUVIMED